San Francisco, United States
Montara Therapeutics, Inc., founded in 2023, is a San Francisco–based precision-medicine neuroscience biotech startup. With the slogan, "At Montara, we’re developing safer, more efficacious therapies to improve the lives of patients with CNS diseases," the startup targets the challenging field of central nervous system (CNS) diseases through innovative approaches.
The team at Montara is comprised of professionals with experience from successful biotech firms such as Mitokinin, Denali, and Soteria, and benefits from a world-class Scientific Advisory Board. Their unique focus on enzyme activators and domain expertise in mitophagy set them apart in their pursuit of creating precision medicine therapies with genetically validated targets.
Recently, Montara secured an $8.00M Seed Round investment on July 30, 2024, backed by notable investors like KdT Ventures, Dolby Ventures, Dementia Discovery Fund, and Two Bear Capital, indicating strong financial support and confidence in their innovative mission.
